Madrigal Pharmaceuticals, Inc. (MDGL) Profit Margins
Over the twelve months to 2026-06-30, Madrigal Pharmaceuticals, Inc. (MDGL) had operating margin -25.1%, net margin -25.3%, free cash flow margin -16.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDGLMadrigal Pharmaceuticals, Inc.Follow MDGL — free
—
Price chart with a free account
- Market cap
- 10.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2012 Dec 12 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | — | 96.5% | — | — | |
| Operating margin | -41456.5% | -276.4% | -31.3% | -25.1% | |
| Net margin | -42714.3% | -258.6% | -30.1% | -25.3% | |
| FCF margin | -37170.1% | -253.7% | -19.8% | -16.1% |
USD billions · SEC XBRL
Madrigal Pharmaceuticals, Inc. — questions
- What is Madrigal Pharmaceuticals, Inc.'s operating margin?
- -25.1% over the twelve months to 2026-06-30.
- What is Madrigal Pharmaceuticals, Inc.'s net profit margin?
- -25.3% over the twelve months to 2026-06-30.
Every figure on this page comes from Madrigal Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.